chr16-11897876-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002094.4(GSPT1):āc.400A>Gā(p.Asn134Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,543,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002094.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSPT1 | NM_002094.4 | c.400A>G | p.Asn134Asp | missense_variant | 3/15 | ENST00000434724.7 | NP_002085.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSPT1 | ENST00000434724.7 | c.400A>G | p.Asn134Asp | missense_variant | 3/15 | 1 | NM_002094.4 | ENSP00000398131.2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000720 AC: 13AN: 180484Hom.: 0 AF XY: 0.0000520 AC XY: 5AN XY: 96078
GnomAD4 exome AF: 0.0000302 AC: 42AN: 1391688Hom.: 0 Cov.: 25 AF XY: 0.0000305 AC XY: 21AN XY: 689440
GnomAD4 genome AF: 0.000158 AC: 24AN: 152168Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.400A>G (p.N134D) alteration is located in exon 3 (coding exon 3) of the GSPT1 gene. This alteration results from a A to G substitution at nucleotide position 400, causing the asparagine (N) at amino acid position 134 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at